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Abstract Although cytotoxicity and endocytosis of
nanoparticles have been the subject of numerous
studies, investigations regarding exocytosis as an
important mechanism to reduce intracellular nanopar-
ticle accumulation are rather rare and there is a distinct
lack of knowledge. The current study investigated the
behavior of human microvascular endothelial cells to
exocytose cerium dioxide (CeO2) nanoparticles
(18.8 nm) by utilization of specific inhibitors [brefeldin
A; nocodazole; methyl-b-cyclodextrin (MbcD)] and
different analytical methods (flow cytometry, transmis-
sion electron microscopy, inductively coupled plasma
mass spectrometry). Overall, it was found that endothe-
lial cells were able to release CeO2 nanoparticles via
exocytosis after the migration of nanoparticle contain-
ing endosomes toward the plasma membrane. The
exocytosis process occurred mainly by fusion of
vesicular membranes with plasma membrane resulting
in the discharge of vesicular content to extracellular
environment. Nevertheless, it seems to be likely that
nanoparticles present in the cytosol could leave the cells
in a direct manner. MbcD treatment led to the strongest
inhibition of the nanoparticle exocytosis indicating a
significant role of the plasma membrane cholesterol
content in the exocytosis process. Brefeldin A (inhibitor
of Golgi-to-cell-surface-transport) caused a higher
inhibitory effect on exocytosis than nocodazole (in-
hibitor of microtubules). Thus, the transfer from distal
Golgi compartments to the cell surface influenced the
exocytosis process of the CeO2 nanoparticles more than
the microtubule-associated transport. In conclusion,
endothelial cells, which came in contact with nanopar-
ticles, e.g., after intravenously applied nano-based
drugs, can regulate their intracellular nanoparticle
amount, which is necessary to avoid adverse nanopar-
ticle effects on cells.
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Introduction
The impact of nanotechnology in various branches of
industry and in medicine has increased in the last years,
which is reflected by nanoparticles’ use, for example, in
certain products of the food sector (Chaudhry et al.
2008), or for prospective medical applications [e.g., for
optical imaging (Jiang et al. 2010), for cancer therapy
(Hilger 2013; Johannsen et al. 2005), or for drug
delivery (Cho et al. 2008)], as contrast agents (Hahn
et al. 2011), in cosmetics like sun protection agents
(Strobel et al. 2014a) etc. Therefore, humans are
increasingly faced with nanoparticles in daily life.
The loading of cells with nanoparticles plays an
important role for nanoparticles’ biocompatibility. In
this context, there are many studies dealing with
nanoparticles’ uptake in cells by endocytosis processes
(Chithrani et al. 2006; Kim et al. 2006; Lesniak et al.
2012; Ma et al. 2013; Meng et al. 2011; Treuel et al.
2013). Such studies revealed that nanoparticles’ endo-
cytosis is a concentration-, time- and energy-dependent
process (Panyam and Labhasetwar 2003) and that it is
mediated by clathrin, caveolae, and other mechanisms
(Canton and Battaglia 2012). Moreover, it was shown
that endocytosis of nanoparticles is dependent on cell
type and on nanoparticles’ properties, like size, shape,
and surface chemistry [(Canton and Battaglia 2012),
and reviewed in (Oh and Park 2014)].
However, cell loading with nanoparticles is not
only dependent on uptake, but also on time of
intracellular retention and therefore on the behavior
of cells to excrete internalized nanoparticles. A
comprehensive understanding of exocytosis is of
relevance for nanotoxicity assessments and for
toxicity categorization of nanomaterials. Nevertheless
until now exocytosis of nanoparticles has been the
subject of only few studies [reviewed in (Oh and Park
2014)]. Examples are exocytosis of silica (Chu et al.
2011; Hu et al. 2011), gold (Bartczak et al. 2012;
Chithrani and Chan 2007; Wang et al. 2011), or of
polymer nanoparticles (Dombu et al. 2010; He et al.
2013a, b; Panyam and Labhasetwar 2003) in several
tumor and non-tumor cell lines. Based on theses
studies, it seems that exocytosis is a dynamic and
energy-dependent process (Panyam and Labhasetwar
2003) like endocytosis. It is dependent on cell type
(Chithrani and Chan 2007; Chu et al. 2011;Wang et al.
2011), nanoparticle amount in supernatants (Chu et al.
2011), and the nanoparticles’ properties like size
(Chithrani and Chan 2007; Hu et al. 2011), shape
(Chithrani and Chan 2007), and functionalization
(Bartczak et al. 2012). Some studies demonstrated an
involvement of cell membrane cholesterol (Dombu
et al. 2010) and of intracellular membrane transport in
exocytosis processes (He et al. 2013a, b).
Interestingly, cerium dioxide (CeO2) nanoparticles
have been suggested to be included in cosmetics as UV
filters and ROS scavengers (Boutard et al. 2013;
Truffault et al. 2012; Yabe and Sato 2003) or in drugs
for the treatment of medical disorders (Chigurupati
et al. 2013; Karakoti et al. 2008; Niu et al. 2007;
Schubert et al. 2006; Silva 2006). Therefore, a direct
exposure of CeO2 nanoparticles with endothelial cells
will occur, particularly if CeO2 nanoparticles will be
used in intravenously applied medications. Moreover,
CeO2 nanoparticles are present in the air due to their
utilization in automobile catalytic converters (Zheng
et al. 2005) and as automotive fuel additives (Jung
et al. 2005; Park et al. 2008). It was shown that CeO2
nanoparticles were taken up by endothelial cells and
were located perinuclearly (Strobel et al. 2014b), but it
is unclear whether they can be exocytosed from cells.
Therefore, the objective of the present study was to
determine the behavior of endothelial cells to exocy-
tose CeO2 nanoparticles and we asked the following
questions: (1) if nanoparticle intracellular accumula-
tion decreases with increasing time after exposure, (2)
which amounts of nanoparticles are detectable in the
cell supernatants as a general measure of exocytosis
with increasing time after exposure, (3) if nanoparti-
cles are re-arranged within cells after nanoparticle
exposure, and (4) which cellular components are
involved in the exocytosis processes.
Materials and methods
Synthesis of the nanoparticles
Reagents and solvents of synthesis were obtained from
Merck KGaA and Sigma-Aldrich if not otherwise
specified. Ethanol (absolute for analysis) was used
throughout the study.
CeO2 nanoparticles were synthesized using the
method of Chen and Chang (Chen and Chang 2004,
2005). A solution of cerium(III) nitrate hexahydrate
(3 mmol, 1.30 g) in 30 ml of water was stirred at
85 C (oil bath temperature) in a round-bottom flask,
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and 1.5 ml of aqueous ammonia (25 %) was added.
Stirring was continued for 3.5 h while allowing
contact of the solution with air. After cooling to room
temperature and stirring for 15 h, the suspension was
centrifuged at 6,700 g for 15 min, and the precipitated
nanoparticles were purified by redispersion in water
(24 ml) and centrifugation (repeated 3 times), fol-
lowed by redispersion in ethanol (24 ml) and cen-
trifugation (repeated 3 times). They were stored in
ethanol (9 ml). The yield was 340 mg (51 %) of CeO2
nanoparticles. Before their utilization in experiments,
the nanoparticles were redispersed in sterile Millipore
water (centrifugation and redispersion in 1.0 ml
Millipore water; repeated 4 times), were vortexed
and treated with ultrasound (10 min; ultrasound bath
Bandelin Sonorex RK 52 H, Bandelin electronic
GmbH & Co. KG, Germany; HF-power: 60 Weff).
Unlabeled nanoparticles were analyzed via trans-
mission electron microscopy (TEM) and inductively
coupled plasma mass spectrometry (ICP-MS). The
flow cytometry analysis was carried out with ATTO
647 N-labeled nanoparticles.
The labeling reagent ATTO 647 N-APS was pre-
pared from commercial ATTO 647 N NHS ester
(Sigma-Aldrich) by reaction with (3-aminopropyl)-
triethoxysilane (APS). Thus, 0.9 lmol (0.75 mg) of
the NHS ester was dissolved in 70 ll of dimethylfor-
mamide and stirred with 2.0 ml of an APS solution
(1 mM) in ethanol for 2 h at room temperature.
Completeness of the reaction (formation of the
labeling reagent ATTO 647 N-APS) was checked by
thin layer chromatography (silica, chloroform/ethanol
2:1, movement along the plate: retardation factor (Rf)
NHS ester 0.7, Rf ATTO 647 N-APS 0.8). The
solution was diluted with 0.9 ml of ethanol to obtain
a 0.32 mM stock solution of the reactive dye species
(structure see Fig. 1b), which can be stored at 5 C for
at least 2 months (data not shown).
The stability of the label at room temperature in
endothelial cell culture medium was checked by
monitoring the fluorescence spectra on storage in the
dark. To 3.0 ml of the medium, 20 ll of the ATTO
647 N-APS stock solution was added, mixed by
shaking and then measured directly (excitation
640 nm, maximum emission at 660 nm; F900 lumi-
nescence spectrometer; Edinburgh Analytical Instru-
ments, UK) at the time points shown in Fig. 1c.
The CeO2 nanoparticles (100 mg) were dispersed
in ethanol (3 ml) in a 4-ml glass vial with screw cap
and Teflon gasket (Wheaton). After addition of 150 ll
of the ATTO 647 N-APS stock solution, the tightly
closed vial was stirred at 120 C (oil bath temperature)
for 3 h. The label was covalently bonded to the
nanoparticle surface by a transesterification reaction
of the triethoxysilyl group with hydroxy groups on the
CeO2 surface. The particles were isolated by centrifu-
gation (11,000 g; 15 min). Unreacted ATTO 647 N-
APS was removed by redispersion/centrifugation with
ethanol (6 ml, 5 repetitions). The particles were stored
in ethanol. Fluorescence spectra in ethanol dispersion
showed appreciable labeling.
Nanoparticle characterization
To characterize the used nanoparticles, the shape and
size were determined by TEM (JEM 2100 F instru-
ment; Jeol, Tokyo, Japan). The samples were prepared
by spreading ethanol dispersions of the nanoparticles
on a carbon film supported on a 200-mesh copper grid
(Plano GmbH) and drying in air. TEM pictures of the
nanoparticles were analyzed with the program ImageJ
(http://rsb.info.nih.gov/ij/). The diameter of the cir-
cumscribed sphere for all nanoparticles was measured
to obtain their average size due to their different
morphologies.
The hydrodynamic diameters and the f-potentials
of CeO2 nanoparticles (50 lg/ml) in water and cell
culture medium (Gibco MCDB 131 medium (Life
Technologies GmbH, Germany), 10 % (v/v) fetal
bovine serum (FBS; Life Technologies GmbH, Ger-
many), 1 % (v/v) GlutaMAXTM I 100X (Life Tech-
nologies GmbH, Germany), 1 lg/ml hydrocortisone
(Sigma-Aldrich Chemie GmbH, Germany), 10 ng/ml
epidermal growth factor (Life Technologies GmbH,
Germany)) were measured using a zetasizer apparatus
(Nano ZS Malvern Instruments, UK).
The cytotoxicity of similar CeO2 nanoparticles was
investigated in a previous investigation (Strobel et al.
2014b) showing that the used nanoparticle concentra-
tions of the present study did not affect the cells
adversely.
Cell cultures
Immortalized human microvascular endothelial cells
(HMEC-1; Centers for Disease Control and Preven-
tion, USA) were grown in cell culture medium
(Gibco MCDB 131 medium (Life Technologies
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GmbH, Germany), 10 % (v/v) FBS (Life Technolo-
gies GmbH, Germany), 1 % (v/v) GlutaMAXTM I
100X (Life Technologies GmbH, Germany), 1 lg/ml
hydrocortisone (Sigma-Aldrich Chemie GmbH, Ger-
many), 10 ng/ml epidermal growth factor (Life Tech-
nologies GmbH, Germany)) in a humidified incubator
at 37 C in a 5 %CO2 atmosphere by changing the cell
culture medium every 2–3 days. Cell cultures were
subcultivated until reaching 70–85 % confluence
using GIBCO trypsin (Life Technologies GmbH,
Germany) and were free of mycoplasma as it was
regularly tested by PCR.
Investigation of exocytosis via flow cytometry
HMEC-1 were incubated with 1 lg/ml CeO2-ATTO
647 N for 24 h. Then the cells were washed with
Hank‘s BSS (Biochrom AG, Germany) and fresh
nanoparticle-free medium was added. After several
time points, the cells were measured via flow
cytometry [10,000 cells; FACS Calibur (Becton–
Dickinson GmbH, Germany); 635 nm laser; filter:
FI4 661/16; CellQuest ProTM software (Becton–
Dickinson GmbH, Germany)]. For the long time
follow-up (up to 240-h follow-up time), the median
fluorescence intensity (MFI) of the appropriate un-
treated cell population was subtracted from the MFI of
nanoparticle-exposed cells and the ratio of MFI of
follow-up (‘‘48 h’’–‘‘240 h’’) to initial value (‘‘0 h’’
follow-up; cells which were exposed to CeO2 nanopar-
ticles for 24 h) was calculated.
To study the role of cellular constituents in exocy-
tosis of nanoparticles, different inhibitors were used
which affected different cellular structures/compo-
nents. After the 24 h nanoparticle internalization, the
cells were washed and exposed either to fresh nanopar-
ticle-freemedium, to Brefeldin AReadyMade Solution
(0.1 lg/ml for 24 h; Sigma-Aldrich Chemie GmbH,
Germany), to InSolutionTM Nocodazole (10 lg/ml for
24 h; Merck KGaA, Germany), or to methyl-b-cy-
clodextrin (MbcD) (10 mM for 2 or 1 h, follow-up: 22
or 23 h, respectively; Sigma-Aldrich Chemie GmbH,
Germany). 24 h after addition of fresh medium or
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Fig. 1 Nanoparticles’ features. a TEM pictures of the CeO2
nanoparticles show the varying shapes. b Structure of the
reactive dye species ATTO 647 N-APS used for labeling.
c Stability test of the ATTO 647 N-APS label in endothelial cell
culture medium (PAA Laboratories, Pasching, Austria) revealed
the stability of the dye for at least 2 weeks, since 90–95 % of the
initial fluorescence intensity of the ATTO 647 N-APS label was
present after this period
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cytometry (FACS Calibur (Becton–Dickinson GmbH,
Germany); 635 nm laser; filter: FI4 661/16; CellQuest
ProTM software (Becton–Dickinson GmbH, Ger-
many)). The exocytosis rate of each sample was
calculated using the MFI: The MFI of the appropriate
control cell population was subtracted from the MFI of
corresponding nanoparticle exposed cells. The per-
centile ratio of MFI of follow-up (‘‘24 h’’ follow-up
after washing and medium exchange) to initial value
(‘‘0 h’’ follow-up; cells which were exposed to CeO2
nanoparticles for 24 h) was calculated and subtracted
from 100 %, resulting in the exocytosis rate.
Investigation of exocytosis via TEM
HMEC-1 were seeded in 12-well plates and incubated
with 10 lg/ml of CeO2 nanoparticles for 24 h. To
investigate the exocytosis of the nanoparticles, 24 h
after nanoparticle treatment the cells were washed and a
cell culture medium exchange followed to remove the
non-internalized nanoparticles. To inhibit the exocyto-
sis of certain samples, cells were treated either with
Brefeldin A Ready Made Solution (0.1 lg/ml for 24 h;
Sigma-Aldrich Chemie GmbH, Germany), with InSo-
lutionTM Nocodazole (10 lg/ml for 24 h; Merck
KGaA, Germany), or with MbcD (10 mM for 2 h,
follow-up: 22 h; Sigma-Aldrich Chemie GmbH, Ger-
many) in cell culture medium. 24 h after medium
exchange, the cells were washed with Hank‘s BSS
(Biochrom AG, Germany) and fixed for 30 min at
20 C with 2 % glutaraldehyde solution in 0.1 M
cacodylate buffer (pH 7.4, 5 % sucrose). After repeated
rinsing in 0.1 M cacodylate buffer (pH 7.4, 6.8 %
sucrose), specimen was postfixed with a freshly
prepared mixture of 2 % osmiumtetroxide (in distilled
water) and 3 % potassium ferrocyanide (0.2 M ca-
codylate, pH 7.4) for 2 h at 4 C followed by thorough
washing in 0.1 M cacodylate buffer (pH 7.4) until the
solution remained clear. Tissue sample was dehydrated
in graded ethanol series and embedded in Epon 812
(FERAK, Berlin, Germany) via acetonitrile as inter
medium. Samples were polymerized at 60 C for
7 days. Ultrathin sections prepared with low-angle
diamond knives were mounted on formvar-coated
copper rhodium grids and stained with 1 % uranylac-
etate (in methanol) and freshly prepared lead citrate
(25 mg/10 ml distilled water). Sections were examined
by an EM 902A (ZEISS, Oberkochen, Germany)
operating with an accelerating voltage of 80 kV.
Investigation of exocytosis via ICP-MS
HMEC-1 were treated with 100 lg/ml CeO2 nanopar-
ticles to be above the detection limit of the method.
After 24 h of nanoparticle exposure, the cells were
washed and nanoparticle-free cell culture medium was
added to the cells either with or without MbcD
(10 mM for 2 h, follow-up: 22 h; Sigma-Aldrich
Chemie GmbH, Germany). After appropriate incuba-
tion time, the cell culture supernatant was collected.
7 ml HNO3 (HNO3 65 %; Merck, cleaned by subboil-
ing distillation) was added to 1 ml of each cell culture
supernatant and a microwave-assisted digestion (Mars
5Xpress, CEM) followed. The cell culture supernatant
samples were filled up to a final volume of 25 ml with
deionized water (GenPure UV-TOC, Fisher Scien-
tific). The concentration of cerium (Ce) in the
appropriate digestion solution was determined via
ICP-MS (XSeriesII, Thermo Fisher Scientific). For
each sample, three measurements were done.
Statistical analysis
During data analysis, the mean values and the standard
deviations were calculated. Statistical data evaluation
was carried out via ANOVA and post hoc Bonferroni
test using IBM SPSS Statistics (version 22.0, Inc, IBM
Company, USA). Data were stated as statistically
significant if P B 0.05.
Results
CeO2 nanoparticle characterization
The morphology of the used nanoparticles varied from
octahedral to spherical (Fig. 1a; Table 1) with an
average size of 18.8 ± 4.5 nm (Table 1). The degree
of clustering varied over a large range, but it could not
be quantified from TEM pictures. Dynamic light
scattering (DLS) measurements suggested a strong
clustering behavior of nanoparticles in the presence of
cell culture medium (Table 1). The f-potential of
nanoparticles changed from positive to negative when
the nanoparticles were suspended in FBS-containing
cell culture medium (10 %) indicating the occurrence
of protein adsorption on the nanoparticles’ surface
(Table 1). Unlabeled and labeled nanoparticles re-
vealed similar properties (Table 1). Therefore,
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nanoparticle labeling should have no distinct effect on
their uptake and exocytosis by the target cells.
The labeled nanoparticles were stable for at least
two weeks, since 90–95 % of the initial fluorescence
intensity of the ATTO 647 N-APS label was present
after this period of time, as the stability test in cell
culture medium showed (Fig. 1c).
Exocytosis of nanoparticles
Decrease of intracellular nanoparticle accumulation
and partial re-uptake of exocytosed nanoparticles
with increasing time after exposure
The analysis of the ability of HMEC-1 to exocytose
nanoparticles generally showed a continuing reduction
in the MFI of the cell population with increasing
follow-up time after the cells were treated with
nanoparticles (Fig. 2a). For example, cells which
were exposed to nanoparticles for 24 h (correspond
to follow-up time point ‘‘0 h’’) and then washed and
supplied with fresh nanoparticle free medium, re-
vealed approximately 70 % of the initial MFI value
(value at ‘‘0 h’’ follow-up) at 48 h after the medium
exchange (‘‘48 h’’ follow-up time), 35 % after 72 h,
only 1.7 % after 120 h, and 0.3 % after 240 h
(Fig. 2a). Since the fluorescence correlated with the
internalized nanoparticle amount, this decrease indi-
cated a nanoparticle reduction within the cell
population.
The Ce content in the cell culture medium super-
natants of cells, which were exposed to CeO2
nanoparticles for 24 h and then processed as men-
tioned above, confirmed the exocytosis of intracellular
nanoparticles at the different time points (Fig. 2b).
The cell culture supernatants of the 48 and 72-h
follow-up presented lower Ce concentrations than the
24 h follow-up samples (Fig. 2b). These findings
could be a result of partial re-uptake of already
exocytosed nanoparticles in HMEC-1.
Intracellular re-arrangement of nanoparticles
with increasing time after exposure and role
of cellular constituents in nanoparticle exocytosis
The investigation of the intracellular localization of
nanoparticles with increasing follow-up time after
exposure revealed a re-arrangement of the nanoparti-
cles within cells. TEM images of the follow-up time
point ‘‘0 h’’ (HMEC-1 were treated with CeO2
nanoparticles for 24 h) showed the endocytosis pro-
cess of the nanoparticles (Fig. 3a). The internalized
nanoparticles were found mainly in endosomes
(Fig. 3b) and partly in the cytosol (Fig. 3c). At this
time point no exocytosis or exocytosis initiation could
be observed.
TEM images of HMEC-1, which were firstly
treated with nanoparticles for 24 h and then washed
and supplied with fresh nanoparticle free medium,
(Fig. 3d–i) disclosed 24 h after the medium exchange
(‘‘24 h’’ follow-up time) a localization of the nanopar-
ticles partly in the cytosol (Fig. 3d) and rarely in
lysosomes (Fig. 3e) as well as a migration of the
endosomal vesicles with the nanoparticles toward the
Table 1 Characterization of the used CeO2 nanoparticles regarding shape, size, and f-potential
With ATTO dyed Without ATTO dyee
Shape Octahedral/spheres Octahedral/spheres
Size (nm)a 18.8 ± 4.5 18.8 ± 4.5
Size in H2O (nm)
b 65 ± 1 79 ± 1
Size in cell culture medium (nm) shortly after preparationb,c 309 ± 9 369 ± 16
Size in cell culture medium (nm) after 3 h incubationb,c 307 ± 1 352 ± 6
f-potential in H2O (mV) 18.7 ± 0.5 18.4 ± 1.0
f-potential in cell culture medium (mV)c -24.1 ± 0.3 -23.8 ± 0.6
a By TEM
b By DLS (polydispersity index\0.5)
c Cell culture medium supplemented with 10 % FBS
d Nanoparticles which were labeled with the dye ATTO 647 N-APS were used in flow cytometry analysis
e Unlabeled counterparts were used for TEM and ICP-MS analysis
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plasma membrane (Fig. 3e–h). Moreover, the ini-
tiation (Fig. 3e, f) and occurrence (Fig. 3h, i) of
exocytosis of the internalized nanoparticles were seen
clearly. Since hardly no extracellular nanoparticles
were observed in TEM images of cells which have
been treated with inhibitor (Fig. 3j–l, n, o), the
extracellular localization of nanoparticles in relation
to non-inhibited cells (Fig. 3h, i) evidences the
presence of exocytosis. The exocytosis process seems
to occur mainly by fusion of the endosomal membrane
with the plasma membrane.
Cells,whichwere treated after nanoparticle exposure
with the inhibitors brefeldin A (Fig. 3j, k; 0.1 lg/ml,
24 h), nocodazole (Fig. 3l, m; 10 lg/ml, 24 h), or
MbcD (Fig. 3n, o; 10 mM, 2 h) to detect the role of
cellular constituents in the exocytosis of nanoparticles,
presented considerably large nanoparticle-containing
endosomes (Fig. 3j, l, n). This indicated the inhibition
of exocytosis. Occasionally, a localization of nanopar-
ticles in secondary lysosomeswas detected for brefeld-
in A and MbcD-treated cells. In analogy to the native
cells (no inhibitor, Fig. 3c), nanoparticles were also
found in the cytoplasm of cells additionally exposed to
inhibitors (Fig. 3k, m, o). In both cases, the occurrence
of nanoparticles in the cytoplasm indicated the pres-
ence of endosomal perforation possibly due to a too
high amount of nanoparticles which accumulated
within the endosomes. Interestingly, it seems that
nanoparticles which already translocated to the cyto-
plasm could be expelled from endothelial cells due to
the close vicinity of cytosolic nanoparticles to the
plasma membrane in representative TEM images
(Fig. 3f, i, m (arrows)). TEM images of nocodazole-
treated cells showed a migration of small endosomes
containing nanoparticles toward the plasma mem-
brane. It was detected that nocodazole permitted an
occasional exocytosis of some single nanoparticles
(Fig. 3m), which was hardly the case for brefeldin A or
MbcD. Overall, cells treated with one of the three
inhibitors showed no or hardly any exocytosis whereby
MbcD showed the best inhibitory effect among all the
applied inhibitors.
To quantify the inhibitory effect of each inhibitor,
the assessment of the exocytosis rate via flow
cytometry analysis was performed (Fig. 4a, b) as
described in the experimental section. The optimal
nanoparticle concentration for the flow cytometry
analysis was 1 lg/ml (exposure time: 24 h) as it was
demonstrated in a preliminary test (data not shown).
Within 24 h after medium exchange, an average
exocytosis rate of 62 ± 5 % was detected (Fig. 4a).
In comparison to the other inhibitors, MbcD with an
exposure time of 2 h led to the strongest inhibition of
nanoparticle exocytosis (exocytosis rate: 22 ± 3 %,
Fig. 4a). MbcD with a shorter exposure time (1 h) led
to a weaker inhibition of exocytosis (exocytosis rate:
55 ± 2 %, Fig. 4a) indicating that the cholesterol
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Fig. 2 Decrease of intracellular nanoparticle accumulation and
partial re-uptake of exocytosed nanoparticles with increasing
time after exposure. a With increasing follow-up time after
nanoparticle exposure a continuous decrease of the intracellular
fluorescence intensity was observed. This indicates a cellular
nanoparticle decrease as result of exocytosis and cell division
(‘‘nanoparticle dilution’’). n = 3 independent experiments;MFI
median fluorescence intensity of the cell population; asterisks
indicate significant differences (P B 0.05) to the initial value
(‘‘0 h’’ follow-up; 100 %), different letters indicate significant
differences (P B 0.05) between different time points. b The
occurrence of cerium (Ce) in the supernatant of endothelial
cells, which were previously exposed to CeO2 nanoparticles and
which were followed up after washing and cell culture medium
exchange (nanoparticle free medium), revealed the occurrence
of exocytosis of intracellular nanoparticles. The lower Ce
supernatant concentrations which were found with increasing
follow-up time (48 and 72-h follow-up time) in comparison to
24-h follow-up time indicate a re-uptake of exocytosed
nanoparticles in cells. The Ce content in supernatants of cells,
which were not treated with nanoparticles, was below the
detection limit. n = 2 independent experiments
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As a consequence of brefeldin A treatment, an
exocytosis rate of 43 ± 3 % was found, which means
that an inhibition of nanoparticle exocytosis occurred
(Fig. 4a). The applied inhibitor nocodazole caused no
obvious inhibition of nanoparticle exocytosis (exocy-
tosis rate: 59 ± 2 %, Fig. 4a). Thus, the transfer from
distal Golgi compartments to the cell surface influ-
enced the exocytosis process of the CeO2 nanoparti-
cles to a higher extent than the microtubule-associated
transport.
The detected Ce concentration in cell culture
medium supernatants of cells, which were washed
and supplied with fresh nanoparticle free cell culture
medium after nanoparticle exposure, in comparison to
those of cells, which were additionally treated with the
inhibitor MbcD, confirmed the inhibitory effect of
MbcD in the exocytosis of CeO2 nanoparticles
(Fig. 4c).
Discussion
Our study has yielded the following results: (1)
Endothelial cells are able to release CeO2 nanoparti-
cles via exocytosis to reduce the intracellular nanopar-
ticle accumulation. (2) A partly re-uptake of the
already released nanoparticles occurs. (3) After uptake
the nanoparticles were mainly localized in endosomes,
which migrated toward the plasma membrane and
released the nanoparticles in the extracellular envi-
ronment via membrane fusion. The nanoparticles were
partly found in the cytosol and rarely in lysosomes.
Apart from their release via fusion of vesicles with the
plasma membrane, nanoparticles seem to also be able
to directly leave the cells. (4) The cholesterol content
of the cell membrane plays an important role in the
exocytosis process. The transfer from distal Golgi
compartments to the cell surface influenced the
exocytosis process of the CeO2 nanoparticles more
than the microtubule-associated transport.
In the present study, flow cytometry analysis
showed a reduction of MFI in the cell population with
increasing follow-up time after extracellular nanopar-
ticle exposure. This was attributed, at least in part, to
exocytosis. However, considering the doubling time of
the used HMEC-1 cells (approximately 33.6 h), it
should be taken into account that the MFI decrease of
flow cytometry analysis, besides exocytosis, may
result in part also from cell division which can lead
to a nanoparticle dilution within the cell population as
it was shown by other researches (Errington et al.
2010; Kim et al. 2012; Summers et al. 2011). It is
discussed that the distribution of nanoparticles during
cell division occurs asymmetrically (Errington et al.
2010; Summers et al. 2011) with the aim to inherit the
foreign substance mainly by one of the daughter cells
in order to ensure survival of the remaining cell
population (Summers 2010). This means that the cell
population contained cells with a high nanoparticle
amount on one side, and on the other cells with low or
even no nanoparticles. On account of the influence of
cell division on the MFI, it is necessary to use not only
flow cytometry analysis for exocytosis studies, but
also complementary methods to verify the obtained
results. Thus, in this study the exocytosis process was
confirmed by TEM, flow cytometry, and ICP-MS
analysis in combination with certain inhibitors.
In this context, the occurrence of Ce in cell culture
medium supernatants of cells after several time points
after finalization of the nanoparticle exposure con-
firmed the exocytosis of CeO2 nanoparticles from
endothelial cells. It was perceived that with longer
follow-up time (48 h; 72 h) the Ce concentrations of
the corresponding cell culture supernatants were lower
than those related to a 24-h follow-up time. This
finding can be explained by a re-uptake of already
exocytosed nanoparticles by HMEC-1, because endo-
cytosis and exocytosis seem to be dynamic processes
which occur simultaneously and are dependent from
the nanoparticle amount outside and inside of cells
(Chu et al. 2011).
bFig. 3 Intracellular localization of nanoparticles with increas-
ing time after exposure and after inhibitor application. TEM
images of HEMC-1 after treatment with 10 lg/ml CeO2
nanoparticles for 24 h show endocytosis (a) and the internalized
nanoparticles in endosomes (b) as well as in the cytosol (c).
TEM images of the localization of the nanoparticles 24 h after
washing and medium exchange with nanoparticle free medium
(d–i) revealed clearly the initiation (e, f) and occurrence (h, i) of
exocytosis of the internalized nanoparticles. Cells treated with
brefeldin A (j, k; 0.1 lg/ml, 24 h), nocodazole (l,m; 10 lg/ml,
24 h), or MbcD (n, o; 10 mM, 2 h) revealed no or hardly any
exocytosis (m), but the localization of nanoparticles in large
endosomes (j, l, n) or in the cytoplasm (k,m, o). The occurrence
of nanoparticles in the cytoplasm indicated endosomal perfo-
ration. Arrows (f, i, m) point to the cytosolic nanoparticles
which are shortly before exocytosis. Scale bars: 0.1 (m); 0.3 lm
(b, c, d, f); 0.5 lm (i); 1.0 lm (e, g, j, k, n); 1.5 lm (a, h); 2.0 (l,
o)
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Fig. 4 Strong inhibitory effect of MbcD and brefeldin A
indicates the important role of plasma membrane cholesterol
and Golgi-to-cell-surface-transport, respectively, during
nanoparticles exocytosis. a The average exocytosis rate of
CeO2 nanoparticles (treatment dose 1 lg/ml for 24 h) within
24 h was 62 ± 5 %. Nocodazole led to no obvious inhibition of
nanoparticle exocytosis (exocytosis rate: 59 ± 2 %). The
highest inhibition of exocytosis was caused by MbcD with an
exposure time of 2 h indicating an important role of plasma
membrane cholesterol for exocytosis. Brefeldin A treatment
resulted also in an inhibition of exocytosis revealing an
involvement of Golgi-to-cell-surface-transport in exocytosis
process. Different letters indicate significant differences
(P B 0.05) between the various treatments. n C 3 independent
experiments; b Histograms of a representative flow cytometry
analysis; NPs: nanoparticles. c The determination of cerium
(Ce) in the supernatant of HMEC-1, which were exposed to
nanoparticles for 24 h, revealed 24 h after washing and cell
culture medium exchange (nanoparticle free medium) a higher
amount of Ce than the supernatants of HMEC-1 which were
additionally treated with MbcD-containing cell culture medium
after washing and medium exchange. This confirmed the
inhibition of exocytosis by MbcD. The Ce content in
supernatants of cells, which were not treated with nanoparticles,
was below the detection limit. n = 2 independent experiments
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TEM analysis indicated that the exocytosis process
occurred mainly via fusion of vesicular (especially
endosomal) membranes with the plasma membrane,
leading to the release of the vesicular content into the
extracellular environment. But also a further exocy-
tosis way was detected: The rupture of endosomes
which contained nanoparticles (perhaps due to the
high amount of internalized nanoparticles) led to the
translocation of released nanoparticles to the cyto-
plasm and from there the nanoparticles seemed to be
expelled directly from endothelial cells presumably
via unspecific mechanisms.
The application of the different inhibitors clarified,
which intracellular pathways are important for exocy-
tosis. In this context, after treatment of cells with
MbcD a strong inhibitory effect on exocytosis was
observed via TEM (very large endosomes of cells
with MbcD treatment and hardly no fusion of vesicles
containing nanoparticles with the plasma membrane),
flow cytometry (lower exocytosis rate of MbcD-
treated cells in comparison to non-treated cells), and
ICP-MS analysis (lower Ce concentrations in cell
culture medium supernatants of cells treated with
MbcD in comparison to non-treated cells). MbcD, a
cyclic oligosaccharide, consists of 7 glycopyranose
units, which form a hydrophobic cavity, where
cholesterol will be incorporated (Pitha et al. 1988)
and making it soluble in the aqueous cell culture
medium (Klein et al. 1995; Ohtani et al. 1989). MbcD
removes the cholesterol selectively from the cell
plasma membrane without membrane incorporation
(Klein et al. 1995; Ohtani et al. 1989). Thus, the
inhibitory effect of MbcD on exocytosis of CeO2
nanoparticles from endothelial cells indicated a sig-
nificant role of cholesterol for nanoparticle exocyto-
sis. A shorter incubation time with MbcD resulted in a
much lower inhibition of exocytosis, most likely due
to an insufficient reduction in the cell membrane
cholesterol content. This finding emphasizes the
importance of cell membrane cholesterol for exocy-
tosis processes. Interestingly, the detected inhibitory
effect of cholesterol depletion on CeO2 nanoparticle
exocytosis from endothelial cells is concordant with
findings related to maltodextrin nanoparticles
(ø & 60 nm by laser light scattering) exposed to
airway epithelium cells (Dombu et al. 2010), but in
contrast to published data regarding polymer nanopar-
ticles (ø & 80 nm by DLS) and MDCK (He et al.
2013a) or Caco-2 epithelial cells (He et al. 2013b),
where the extraction of cholesterol improved exocy-
tosis. This indicates a nanoparticle and/or cell type
dependency of nanoparticle exocytosis pathways. A
study comparing the ability of three different cell
types (lung carcinoma (A549), bronchial epithelial
(16HBE), and primary adult stem cells (MSC)) to
exclude gold nanorods within 72 h from the cells
reported that only the stem cells excreted the inter-
nalized nanoparticles (Wang et al. 2011), which also
suggests a cell type dependency in nanoparticle
exocytosis. Cell type-specific differences [human
esophageal epithelial cells (NE083) and human
lung carcinoma cells (H1299)] were also observed
in the exocytosis of silica nanoparticles (Chu et al.
2011).
Brefeldin A treatment also caused an inhibitory
effect on nanoparticle exocytosis, but to a lesser extent
than MbcD. TEM images of nocodazole exposed cells
revealed an occasional exocytosis of some single
nanoparticles, but overall this was very low in com-
parison to the exocytosis process of non-treated cells.
The contradictory findings between flow cytometry
and TEM analysis in relation to nocodazole co-
incubation of cells (flow cytometry: ineffectiveness
of inhibition, quantitative analysis; TEM: only rarely
exocytosis; snap-shot analysis) emphasize the impor-
tance to verify the exocytosis results with more than
one analysis method. Overall, the results regarding
brefeldin A and nocodazole suggest that the transfer
from distal Golgi compartments to the cell surface
[should be inhibited by brefeldin A (Miller et al. 1992)]
influences the exocytosis process of the CeO2 nanopar-
ticles more than the microtubule-associated transport
[should be inhibited by nocodazole (Peterson and
Mitchison 2002)]. The involvement of Golgi to plasma
membrane pathway in nanoparticle exocytosis seems
to be generally of importance as this pathway was also
shown for other nanoparticles (polymer nanoparticles,
ø & 80 nm by DLS) and cell systems [MDCK and
Caco-2 epithelial cells (He et al. 2013a, b)].
On the whole, the present study showed that
endothelial cells are able to excrete internalized
nanoparticles to control their nanoparticle loading
mainly via the plasma membrane cholesterol-depen-
dent mechanisms. While the Golgi to plasma mem-
brane pathway is also important for CeO2 nanoparticle
exocytosis, the microtubule-associated transport
seems to play only a marginal role. The exocytosis of
nanoparticles should be very important for the cell to
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prevent cell damage with the final consequence of cell
death as a result of excessive nanoparticle enrichment.
Conclusions
It can be concluded that endothelial cells, which are
the first barrier after nanoparticles arrived at the blood
system, are able to remove internalized nanoparticles
by exocytosis processes. After uptake, the internalized
nanoparticles are re-arranged within cells—the
nanoparticle containing vesicles (mainly endosomes)
migrates to the plasma membrane. The exocytosis
process occurs mainly by fusion of endosomes with
the plasma membrane, but probably also—to a less
extent—by a direct release of free cytosolic nanopar-
ticles. The already exocytosed nanoparticles can also
be re-taken up by cells. An important role of plasma
membrane cholesterol was identified for the exocyto-
sis process. Furthermore, the transfer from distal Golgi
compartments to the cell surface seems to influence
the exocytosis process of the CeO2 nanoparticles more
than the microtubule-associated transport. A sufficient
exocytosis of nanoparticles should protect endothelial
cells for adverse effects of nanoparticle accumulation.
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